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The primary outcome of Randomized clinical Trials (RCTs) are typically dichoto-
mous, continuous, multivariate continuous, or time-to-event. However, what if
this outcome is unstructured, e.g., a list of variables of mixed types, longitudinal
sequences, images, audio recordings, etc. When the outcome is unstructured it is
unclear how to assess RCT success and how to compute sample size. We show that

























demonstrate our approach with the measurements of computer usage in a cohort of
aging participants, some of which will become cognitively impaired. Simulations
as well as a real data experiment show the superiority of the proposed approach
compared to the standard in this situation: generalized mixed effect models.
1 Introduction
Lower back pain (LBP) represents the leading cause of years lived with disability globally, ranking
first in both developed and developing countries, see [1]. How to test whether patients with back
pain will benefit more from, say acupuncture, compared to acupressure? one of the difficulties in
conducting a trial is that there is no consensus on the primary outcome. Actually, there would possibly
be consensus in case the primary outcome would combine physical functioning, pain intensity, and
health-related quality of life. However, how do we assess RCT success and compute sample size with
a high dimensional primary outcomes?
A second example is provided by holistic medicine. The Academy of Integrative Health & Medicine
define health as the conscious pursuit of the highest level of functioning and balance of the physical,
environmental, mental, emotional, social and spiritual aspects of human experience, resulting in a
dynamic state of being fully alive. One of the challenges of organizing a RCT in holistic medicine is
to define an acceptable primary outcome. It is likely that any consensus on the primary outcome will
lead to a high dimensional primary outcome.
For still another example, consider the case of aging subjects living in homes with embedded
technology, measuring their sleep patterns, computer usage, walking speed, and more, see e.g. [2].
One might be interested in a treatment involving regular video-conferencing for increased social
interactions, see [3]. How to “best" quantify the efficacy of this treatment in slowing the progression of
cognitive impairment? The current approach consists in bi-yearly hospital visits where cognitive tests
are performed. However, the frequency with which these tests are conducted makes them unsuitable
to detect subtle changes in cognitive status, resulting in prohibitively long, large and expensive trials.
Conversely, having technology embedded in people’s homes provides the opportunity to collect high
frequency digital markers, which could potentially be much more sensitive to a treatment. However,
how to design a RCT with high frequency digital markers as primary outcome?
In this paper, we explore the use of kernel methods for designing a simple two-arm RCT when the
primary outcome is a high dimensional or an otherwise complex data type, including sequences,
images, audio recordings, or wearable sensors data.
2 Method
Kernel methods are popular methods in machine learning, see e.g. [4, 5]. Recent developments in
kernel methods allow for performing two sample tests of equality of distributions using Maximum
Mean Discrepancy, see [6] and the kernalized Hotelling’s test [7, 8], Even if more work is needed,
kernel methods allow for a natural generalization of the classical design of a 2-arms randomized
clinical trials (RCT), proceeding as follows:
Step A Map the data aka measurements into a feature space. The feature space is a Hilbert space,
specifically a reproducing kernel Hilbert space, see [4]. This mapping is established by
choosing a kernel function;
Step B Choose a univariate test statistic in feature space using a geometric construction;
Step C Compute the finite sample or otherwise asymptotic distribution of the test statistic under the
null hypothesis. Use this to threshold the test statistic;
Step D Establish a local alternative using another geometric construction in feature space;
Step E Compute the finite sample or otherwise asymptotic distribution of the test statistic under the
local alternative.
Step F Use preliminary data, or a pilot study for computing the effect size. Combine with the
previous step for computing power and sample size;
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The classical construction of RCTs is included in this program. It is the special case where the feature
space is the same as the measurement space. However, accommodating for unstructured primary
outcome requires the more general construction presented. Figure 1 shows a schematic representation
of a specific kernel method approach for determining the outcome of a RCT. It is an example of
this program. Here, data-point are longitudinal sequences and the kernel used is the Fisher kernel.
Alternatives are discussed in the discussion section.
The schematic in Figure 1 reads as follows: before the RCT, during the pre-trial phase, data is
collected from asymptomatic (A) subjects (upper left of figure 1). These subjects determine the
healthy baseline for the trial. We then define a family of models for the data, here a Gaussian
processes with a parameterized mean and covariance operator. We fit this model to the A subjects,
obtaining a parameter vector θ0. The Fisher kernel is then used to map the measaurements to a
Euclidean space of the same dimension as the space of parameters, concluding Step A. The data is
then collected for the RCT, as shown on the upper right side. After the trial ends, Fisher vectors are
computed for each subjects’ sequence of measurements (shown on the bottom right), mapping each
measaurement of the trial into the feature space. The empirical estimate for the mean elements of
both the treatment and control groups are computed (bottom middle). The outcome of the trial is
decided using the Hotelling statistic (bottom left) (Step B). The power is computed under a local
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Figure 1: Schematic representation of Kernel testing approach.
in the Appendix 5.
3 Results
3.1 Simulations
We demonstrate the method described in this paper on an Alzheimer’s data set from the Oregon
Center for Aging and Technology (ORCATECH).
In order to determine the ability of the proposed approach to correctly identify differences between
treatment and control groups we ran a simulation experiment using the strategy described in Figure 1.
Specifically, we first generate data for control group, as well as for treated group using the Gaussian
process model defined in appendix 8. The parameters were fit using the A group in the actual
dataset. In generating the treated subjects, we choose the same parameters, aside for the parameter
µ, see Appendix 8. In these experiments we evaluated how the power changes as a function of the
sample size, and of the frequency (number of time points within a fixed total trial time) at which
the measurements are collected. Results from this simulation experiment are displayed in Figure 2,
which provides the estimated sampling distribution of the p-values when the alternative hypothesis of
3
effective treatment is true. In each case, the power is the integral of the shown distribution on the left
hand side of the α cutoff, e,g, α = 5%. We see that the proposed approach (fvsn) provides better
power than the standard approach: the linear mixed effect model (lmm) in all cases presented, thus
allowing for smaller sample size when planning for a RCT. Note also that measurements collected at
higher frequencies (from left to right in figure 2) systematically improve the power for both methods.

















Figure 2: FvH: Fisher vector Hotelling test, and lmm: linear mixed effect model. n: number of
subjects. t: number of time-points. Note that when the error type I is u (e.g. .05), the power is the
integral of this distribution on the left side of u (e.g. .05).
3.2 Computer usage data
The ORCATECH data set which was used included 86 cognitively normal (CN) subjects and 11
subjects who developped mild cognitive impairment (MCI) during the data collection period. We
considered 150 weeks of computer usage chronological sequences. Details about the preprocessing is
presented in appendix 9. Figure 4 show a few examples of trajectories.
Using the ORCATECH data set we can simulate a RCT using cross validation. First we divide the
86 CN subjects into 8 groups of 11 (two subjects are repeated). For each group we now have 11
"treated" (CN), 11 "control" (MCI), and 75 healthy out of sample (CN). We can then test the Fisher
Kernel technique’s ability to determine the outcome of the 8 simulated RCTs.
To compare the behavior of the proposed approach to more traditional methods, we contrast our
results from a power analysis to those obtained from the linear mixed model. The details of this
approach are presented in Appendix 7.
For this power analysis we considered the alternative distribution given in (13). The results obtained
with the kernel method yield more stable results in this small data example, needing for all data folds
for the CN less than 175 observations to achieve a power of 80%.
4 Discussion and broader impact
We have presented a program for designing a randomized control trial when the primary outcome
is unstructured. We have shown that kernel methods offer a natural generalization of the current
techniques used by bio-statisticians. A key highlights are as follows:
1. A group of asymptomatic as well as a group of symptomatic subjects is used to compute the
mapping into feature space, or equivalently, to compute the kernel during the pre-trial phase.
These groups are also used to compute the sample size. Note that a pilot study is always
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Figure 3: Power vs sample size using the Fisher vector approach (left) and the linear mixed model
(right). Power curves in black obtained using estimates using data from each of the 8 CN groups
considered against the MCI. Red curves correspond to the power curves using the average parameter
estimates from all 8 groups.
available during a pre-trial phase providing the group of symptomatic subjects. The novelty
here is the explicit use of a group of asymptomatic subjects in the design of the trial.
2. The power of the trial is computed using a geometric interpretation: the treatment allows to
translate the -features of - treated group in the direction of the -features of - the asymptomatic
group;
This last statement bring ethical questions. It could be argued that using this program, a treatment,
or drug, could be deemed successful even if no medical landmark has been crossed. On the other
side, some would argue that a computational and data-based notion of health encapsulated in the
definition of a kernel provides a reasonable surrogate when no simple primary outcome is available.
There are also technical questions arising for this work. In particular, it is still a research topic to
compute power for local alternative with the MMD or the kernel Hotelling’s test.
5 Appendix A: Details of the method
5.1 Kernel methods and the feature space
To define the problem more formally, we now set some notation. LetX denote the set of measurements
that will be acquired during a RCT. To work with a concrete example in mind, let us think of the
measurements as longitudinal sequences with missing values spread across. There is no structure
provided with X ; no natural way to add up elements of X for example. Instead, we assume that we
are provided with a mechanism to compare two elements x, x′ ∈ X . Specifically, we assume that the
similarity between x and x′ is defined by a positive definite kernel K(x, x′). In section 5.6, we will
discuss options to estimate a kernel using a dataset of healthy subjects, but until then, let us assume
that this kernel is given to us. One way to visualize the action of a kernel is to think of it as a mapping
φ from X to a vector space H , also called the feature space, or in other words, each observation
x ∈ X is mapped to a vector φx.
x ∈ X 7→ φx ∈ H. (1)
During a two-armed RCT, the subjects in both groups (treatment and control) are mapped onto vectors
in the feature space. If vectors from the two groups are clustered together, the trial is unsuccessful.
However, if it is not the case, should the trial be consider successful? Note that in the case of a low
dimensional outcome, think of blood pressure (2 dimensions), medical science allows to define the
range of measurements with are consistent with an asymptomatic subject, eventually correcting for
the effect of age, sex, and other covariates. In the case of unstructured primary outcome, there is
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no such science available to define a beneficiary treatment. Instead, we propose to use a dataset of
asymptomatic subjects. Then, if the treatment allows to geometrically translate the feature vector of
the treated subject in the direction of the feature vector of the asymptomatic group, the trial will be
successful, pending it is significant.
The fact that the kernel is positive definite lends more structure to the feature space H . It provides
an inner product such that norms, orthogonal projection, and other simple geometric constructions
can be obtained. In some cases the mapping described above is explicit and can be computed for
each observation. In other cases it is implicit and only the kernel K is provided. In the former case,
most quantities of interest can still be computed, using the “kernel trick", see [4]. Note that the set
H can be infinite dimensional, specifically a set of functions. This explains why we use φx instead
of φ(x), which allows us to denote by φx(y) the yth coordinate of φx, both in the finite and infinite
dimensional cases.
Coming back to the technical aspects of the RCT setting, how to measure the separation between the
two groups of vectors? There is not a single way to do this. However, there are simple geometric
constructions that provide alternative answers. A few of these will be reviewed in Section 5.4. In all
cases, a univariate positive test statistic, notated, U2 is computed. The trial is then successful if and
only if the tests statistic exceeds some predetermined threshold u20. Computing the threshold as well
as estimating the power of the test requires computing probabilities in H which we discuss next.
5.2 Mean and covariance operators
Consider a probability measure P defined over X . For example, consider a finite set of observations
x1, . . . , xn and consider the empirical distribution over these observations. Now, map this probability
in feature space using (1). Does this provide a probability distribution over H? It doesn’t because H
is much larger, and thus most elements of H have no weight! However, P allows to define the mean
element µ ∈ H , by
µ = E[φX ] = E[K(X, .)], where X ∼ P. (2)
Surprisingly, even though it is a single point in H , the mean carries a lot of information about P. If
the Kernel is characteristic, see e.g. [9], all the information about P is encapsulated in µ and revealed
by computing inner products. For any f ∈ H ,
E[f(X)] = 〈µ, f〉H (3)
If the mean element allows us to compute the expected values of functions of a random element
X ∈ X , what about the covariance between two functions f and g of a random element X ∈ X ?
This can be computed using the covariance operator, which is the linear operator ΣX : H → H
defined by
Cov[f(X), g(X)] = 〈f,ΣXg〉H (4)
5.3 Randomized clinical trials
We consider a simple two armed RCT. In the treatment arm, we observe ~xT = (x1, . . . , xnT ), while
in the control, or untreated arm, we observe ~xC = (y1, . . . , ynC ). Each of the nT + nC observations
belong to X . ~xT and ~xC are random samples from the respective probabilities PT and PC over
X . Assessing the success or failure: H0 : PT = PC of the trial consists in calculating a statistic
U2(~xT , ~xC) and comparing it to a threshold u20. This threshold is such that
PH0(U
2 > u20) = α (5)
for a preset value α, say α = 5%. The trial is a success when the actual value u2 observed satisfies
u2 > u20. The performance of the test procedure is characterized by the power of the test
β = PHa(U
2 > u2) (6)
where Ha is a specific alternative hypothesis.
5.4 Test statistics for kernel methods
We present two test statistics that have been introduced for kernel methods.
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5.4.1 Maximum Mean Discrepancy
Recall that a kernel maps each data point in X to a vector in H . A natural idea for measuring how
the two arms differ is as follows:
1. Map each data point in the treatment arm to the feature space H and compute the mean
vector in feature space µ̂T ;
2. Map each data point in the control arm to the feature spaceH and compute the corresponding
mean vector µ̂C ;
3. Define the test statistic
Ũ2MMD = ||µ̂T − µ̂C ||2H (7)
It is not difficult to see that µ̂T and µ̂C are the mean elements associated with the empirical probability


















How to compute the threshold u0? one can use the asymptotic distribution of U2MMD under H0 :
PT = PC when both nT and nC are large, use a concentration inequality, or, alternatively, use a
permutation test. For the later, having observed ~xT and ~xC , assign randomly the labels T and C to
the nT + nC samples, while maintaining constant the number of samples in each group and compute
U2MMD. Then, repeat this sampling procedure a large number m of times independently provides
m - dependent - samples of U2MMD, under the null distribution. u0 is then the (1− α) quantile of
the empirical distribution of these samples. Computing power for a local alternative for the MMD
is challenging. Instead, we rely on the Kernel Hotelling test for which computing an approximate
power, when the dimension of the feature space is small, is easier.
5.4.2 Kernel Hotelling test
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and d1 and d2 are constants used to studentize the distribution, that is, insuring that the asymptotic
















The kernel Hotelling statistic generalized the Hotelling statistic to infinite dimensional feature spaces.
However, if the trace of the operator ΣW is not too large, or if the feature space is of finite and small
dimension, one can choose γ = 0 and use the distributional properties of the Hotelling statistic. This
path is taken below in the experiments. However, a more refined analysis might be needed otherwise.
Also, note that there are alternatives to (9). In [10], the Regularized Hotelling’s T2 defined in [11]
is used and the authors provide a data-driven selection mechanism for the regularization parameter
based on maximizing power under local alternatives.
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5.5 Power and sample size with the Hotelling statistic
Computing power and sample size for a RCT requires specifying a single hypothesis Ha ∈ HA.
As discussed in the introduction, we assume that we have access to historical data of asymptomatic
subjects (A) as well as symptomatic subjects (S). From these two dataset, we compute µ̂A and µ̂S ,
the respective empirical mean elements. We then compute the power at
Ha : µT − µC = (1− ρ)(µ̂A − µ̂S) (13)
In words, a successful treatment moves the distribution of the participants in a direction parallel to the
segment connecting the asymptomatic and symptomatic subjects and with proportional magnitude
1− ρ. A typical value for ρ is ρ = 40%. A pilot study would allow us to compute a treatment specific
value for ρ.
The classical finite dimensional distributional results for the Hotelling test allowing to compute power
and sample size are presented in the appendix 6.
5.6 Generative models and Fisher Kernels
A key elements for kernel methods to be effective is to choose, and/or estimate from data an
appropriate kernel. While there are standard techniques for selecting a kernel, we are interested in
data driven techniques. Specifically, we assume that we dispose of one set of observations from nA
asymptomatic subjects ~z = (z1, . . . , znA). Note that even if data might be available for symptomatic
subjects, it makes sense from a statistical perspective to perform modeling only for asymptomatic
subjects which likely form a more homogeneous group. Note that we will still need a sample from
the symptomatic group in order to compute sample size but it is not needed for estimating the kernel.
We now describe the Fisher kernel technique applied to this setting. Alternative techniques include
auto-encoders [12], variational auto-encoders [13] and generative adversarial networks [14]. We
choose a parametric family of probabilities Pθ over X , with θ ∈ Rd. Notate the density or point
mass function f(x, θ), x ∈ X . The parameter θ is then estimated using the data ~z through maximum
likelihood, penalized likelihood or a Bayesian inference. Using this estimate θ̂ we can then calculate
the Fisher information matrix I(θ̂). The Fisher vector is a function of both I(θ̂) and of the Fisher
score. The Fisher score evaluated at a data-point x ∈ X is defined as the gradient of the log density
at that point
φ(x) = ∇θ ln f(x, θ = θ̂). (14)
The Fisher vector of a data-point x at θ is
ψ(x) = I(θ̂)−1/2φ(x), (15)
and is finally used to derive the Fisher kernel, given by
K(x, x′) = ψ(x)Tψ(x′). (16)
.
6 Appendix B
We reproduce here some results related to sample size computations for tests of difference of means
of multivariate Normal distributions (MVN) in dimension p as can be found in [15].
Consider a randomized control trial with two arms. Assume that in the treatment arm, there are nT
iid observations
X1, . . . , XnT with Xi ∼MVN(µT ,Σ) (17)
In the control arm, there are nC iid observations
Y1, . . . , YnT with Yi ∼MVN(µC ,Σ) (18)
Note that the covariance is assumed to be the same in each arm, which is a standard simplifying
hypothesis. The RCT will test
H0 : µT = µC versus (19)
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against a local alternative which we define next. As discussed in t5he main text, we assume that
we have access to historical data of asymptomatic subjects (A) as well as symptomatic subjects (S).
From these two datasets, we compute µ̂A and µ̂S , the respective empirical mean. Note that since the
dimension d is finite, these are the usual empirical means. We then compute the power at the local
alternative
Ha : µT − µC = (1− ρ)(µ̂A − µ̂S) = (1− ρ)d (20)
The test can then be rephrased as
H0 : ρ = 0 versus Ha : ρ = ρ0 (21)
A typical value for ρ0 is 40%. Note also that we assume that the historical data is sufficiently large
compared to the sample size used in the RCT, such that d is considered as a constant and not as
random variable. within these assumptions, the situation is standard in the statistics litterature, and




(x̄− ȳ)T Σ̂−1(x̄− ȳ) (22)
where Σ̂ is the unbiased pooled covariance matrix estimate
Σ̂ =
(nT − 1)Σ̂x + (nC − 1)Σ̂y













(xi − x̄)(xi − x̄)T (24)
and similarly for ȳ and Σ̂y
Moreover, it holds that under H0,
nT + nC − p− 1
(nT + nC − 2)p
T 2 ∼ F (p, nT + nC − 1− p) (25)





then, under Ha, T 2 follows a non-central F-distribution
n1 + n2 − p− 1
(n1 + n2 − 2)p
T 2 ∼ F (p, n1 + n2 − 1− p; δ) (27)
It is common to define the effect size as √
νT Σ̂−1ν (28)
because it provides an expression for the magnitude of the standardized difference between the group
means.
7 Appendix C: linear mixed effect model
yi(t) = β0 + βi0 + β1t+ β2mci.indi + β3mci.indi ∗ t+ εit.
Here β0i denotes a subject specific random intercept, t denotes the week number, mci.indi represents
the indicator variable for the ‘MCI‘ group, and εit denotes an independent error. We are particularly
interested in the power of the coefficient for the interaction term mci.indi ∗ t, which indicates whether
or not the two groups differ in their slopes.
9
8 Appendix D: Gaussian process model for computer usage data
After extensive empirical observation of the computer usage data over time of a collection of elderly
normally aging subjects, we propose the following model. We denote n(t) the number of subjects
observed at time t. We assume that n(t) > 0 over a range [0, T ]. We also denote n(s, t) the number
of subjects observed both at times s and t. We notate ȳ(t) the average computer usage for the subjects
observed at time t. We then propose the following Gaussian Process (GP) model for ȳ(t)









w̄(t) = GP (0,K) (31)







We assume that we observe the process ȳ at a collection of m time points t = (t1, . . . , tm). The
resulting vector
x = (ȳ(t1), . . . , ȳ(tm)) (33)
is then MVN with parameter θ = (θ1 = µ, θ2 = σ2, θ3 = α2, θ4 = β, θ5 = ρ2, θ6 = ν). These
parameter were estimated using the group of asymptomatic subjects. The fitting was obtained using
Bayesian modelling and Hamiltonian Monte-Carlo, see [16].
In the simulation study, the treated subjects are modelled with the same parameters, aside from the










Figure 4: Observed computer usage relative to week 0 for 5 subjects. Left: Mild Cognitively Impaired
subjects. Right: Cognitively normal subjects.
9 Appendix E: preprocessing of the computer usage data fromORCATECH
For each subject, we had up to 250 weekly measurements of computer usage. We picked each
subjects first week as their first complete week within weeks 5-15 of the study to account for
any effects of setting up the monitoring equipment etc. We then selected the subjects next 150
measurements because some subjects were missing data for the remaining 100 weeks. We finally
took each measurement and subtracted the measurement from the first week so that each data point is
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